Sutro Biopharma, Inc. (STRO)
NASDAQ: STRO · Real-Time Price · USD
3.830
+0.040 (1.06%)
Oct 14, 2024, 4:00 PM EDT - Market closed
Sutro Biopharma Market Cap
Sutro Biopharma has a market cap or net worth of $313.92 million as of October 14, 2024. Its market cap has increased by 45.27% in one year.
Market Cap
313.92M
Enterprise Value
-85.55M
1-Year Change
45.27%
Ranking
Category
Stock Price
$3.83
Market Cap Chart
Since September 27, 2018, Sutro Biopharma's market cap has decreased from $336.80M to $313.92M, a decrease of -6.79%. That is a compound annual growth rate of -1.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 11, 2024 | 310.60M | 18.78% |
| Dec 29, 2023 | 261.50M | -43.69% |
| Dec 30, 2022 | 464.40M | -32.55% |
| Dec 31, 2021 | 688.50M | -17.85% |
| Dec 31, 2020 | 838.10M | 229.96% |
| Dec 31, 2019 | 254.00M | 23.24% |
| Dec 31, 2018 | 206.10M | -38.81% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| XOMA Royalty | 322.93M |
| ClearPoint Neuro | 320.39M |
| Aldeyra Therapeutics | 319.09M |
| enGene Holdings | 317.91M |
| Immutep | 314.44M |
| AirSculpt Technologies | 309.85M |
| OraSure Technologies | 305.73M |
| Accolade | 305.24M |